Gosebruch Henry O 4/A
4/A · AbbVie Inc. · Filed May 20, 2022
Insider Transaction Report
Form 4/AAmended
AbbVie Inc.ABBV
Gosebruch Henry O
Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock, $0.01 par value
2022-05-16$54.86/sh+83,960$4,606,046→ 125,583 total - Sale
Common Stock, $0.01 par value
2022-05-16$155.00/sh−83,960$13,013,800→ 41,623 total - Exercise/Conversion
Option (Right to Buy)
2022-05-16$54.86/sh−83,960$4,606,046→ 0 totalExercise: $54.86From: 2017-02-18Exp: 2026-02-17→ Common Stock (83,960 underlying)
Holdings
- 53,500(indirect: By Trust)
Common Stock, $0.01 par value
- 3,638(indirect: By Trust)
Common Stock, $0.01 par value
Footnotes (3)
- [F1]The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.
- [F2]Balance in AbbVie Savings program as of May 18, 2022.
- [F3]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.